Due to “Apparent Loophole” in Statutory Framework, District Court Permits Invalidity Challenge that Does Not Foreclose Later IPR

Apr 15, 2020

Reading Time : 2 min

Epic Games originally filed a complaint for declaratory judgment of non-infringement—but not of invalidity—challenging several of Acceleration Bay’s patents. After Acceleration Bay filed its counterclaims of patent infringement, Epic Games filed counterclaims-in-reply seeking declaratory judgment of patent invalidity (of the same patents that were the subject of the original complaint). Acceleration Bay moved to strike Epic Games’ invalidity counterclaims-in-reply. Acceleration Bay argued that allowing Epic Games’ invalidity counterclaims-in-reply would be an end-run around the rules governing the availability of IPRs.

In analyzing the motion to strike, the court noted that there are two statutes that prevent an accused infringer from taking a “second bite at the apple” after challenging the validity of a patent at the district court. First, under 35 U.S.C. § 315(a)(1), no IPR may be instituted if, prior to filing its petition, the petitioner sought a declaratory judgment of invalidity of the challenged patent. Second, under 35 U.S.C. § 315(b), no IPR may be instituted if the petition was filed more than one year after the petitioner (or a real party-in-interest or privy) was served with a complaint alleging infringement of the challenged patent.

In analyzing the issues, the court noted that Section 315(a)(3) states that a counterclaim challenging the validity of a patent claim “does not constitute a civil action challenging the validity of a claim of a patent” for purpose of Section 315(a)(1). The court also noted the Patent Trial and Appeal Board (PTAB) has held that counterclaims-in-reply are not subject to the bar under § 315(a)(3) because they are not “civil actions” challenging validity. See Canfield Scientific, Inc. v. Melanoscan, LLC, IPR2017-02125 Paper 15, 2018 WL 1628565, at *2-3 (PTAB Mar. 30, 2018).

Ultimately, the court allowed Epic Games’ invalidity counterclaims-in-reply. The court reasoned that striking them would be futile because the court was going to hear the invalidity challenges through Epic Games’ affirmative defenses anyway.

In its penultimate paragraph, the court explicitly recognized that by allowing the invalidity counterclaims-in-reply, Epic Games was able to take advantage of an “apparent loophole” left by the statutory scheme governing IPRs. The court stated that “unlike a patent infringement defendant (which cannot bring an IPR more than one year after being sued) or a declaratory judgment plaintiff seeking a judgment of invalidity (which cannot seek an IPR at all), a declaratory judgment counterclaimant faces no apparent restrictions on seeking an IPR.”  According to the court, this result could, in theory, allow a declaratory judgment counterclaimant to fully litigate the issue of patent validity in the district court, lose on the issue, and then seek a “redo” before the PTAB “while being subject to no estoppel or time limit whatsoever.”  The court recognized that this result cannot be reconciled with the clear congressional intent to limit the availability of IPRs to litigants, but that issue is “one for Congress to resolve.”

Practice Tip:  Potential infringers who wish to litigate validity in district court—while keeping intact their ability to challenge patentability at the PTAB—should consider seeking first a declaratory judgment of non-infringement. If that case proceeds, the patent holder will have to file a counterclaim of infringement or lose its ability to bring such a claim.  That will allow the declaratory judgment plaintiff to litigate validity either through affirmative defenses in its answer to that compulsory counterclaim, or through declaratory judgment counterclaims-in-reply, neither of which—according to this district court decision—should foreclose a later petition for IPR.

Epic Games, Inc. v. Acceleration Bay LLC, 4-19-cv-04133 (N.D. Cal. Apr. 1, 2020)

Share This Insight

Previous Entries

IP Newsflash

June 6, 2025

In a precedential opinion, the Federal Circuit definitively held that the Patent Trial and Appeal Board has jurisdiction over IPRs that concern expired patents.

...

Read More

IP Newsflash

June 6, 2025

In a patent infringement litigation in the U.S. District Court for the Eastern District of Texas, Judge Rodney Gilstrap denied a joint motion to stay the litigation pending resolution of inter partes review when it was uncertain that all defendants would be bound by the statutory estoppel provision of 35 U.S.C. § 315(e).

...

Read More

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.

...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.

...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and the related statutory context.

...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged claim construction issues or the number, length or scope differences of the challenged claims.

...

Read More

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel litigation. Weighing the factors as a whole, the Director determined that institution should be denied.

...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.